Pendulum Therapeutics
Biotechnology • San Francisco, United States
Pendulum Therapeutics is the leading innovator in microbiome science, delivering research based probiotic formulations to support metabolic health. The company leverages cutting-edge research and strong intellectual property to bring effective, science-backed solutions to consumers worldwide. Pendulum Akkermansia was the first novel species to be brought to the probiotics market in more than 50 years. The first and only probiotic in the world clinically proven to lower A1C and blood glucose in people with type 2 diabetes, Akkermansia stimulates natural GLP-1 production.
Reported headcount
118
Headcount reported in the resolved company record. It is independent of the number of profiles indexed by Super Carl.
Company record. Source date unavailable.
Observed active job postings
13
Active postings in the available job data. Postings may be duplicated or stale and are not a verified count of vacancies or hires.
Indexed job postings. Source date unavailable.
Reported annual revenue estimate
$3M
Annual revenue from the resolved company record; estimates may differ from filed accounts.
Company record. Source date unavailable. Estimate.
Calculated as of 2026-09-22. Source records may be older.
